Prasad Neerati | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Prof. Prasad Neerati | Pharmacology | Best Researcher Award

Kakatiya University, India

Author Profile

Early Academic Pursuits 🏫

Prof. Neerati Prasad’s academic journey began with a solid foundation in the sciences. He completed his Secondary School Certificate (SSC) in 1991 with a first-class division, securing 74.16% marks. His thirst for knowledge continued as he excelled in his Intermediate studies, achieving 89.53% in 1994 under the Board of Technical Education. His academic journey took a decisive turn when he pursued his undergraduate degree at Kakatiya University, Warangal, where he graduated in 1999 with 65.80% marks. His passion for pharmaceutical sciences grew stronger during his postgraduate studies, also at Kakatiya University, where he emerged as a University Topper 🏆 in 2002, with a distinction and a remarkable 75.50%.Prof. Prasad’s pre-PhD academic qualifications were equally impressive, as he continued his studies at Kakatiya University, securing 70.1% marks in 2007. This solid academic grounding paved the way for his remarkable research career.

Professional Endeavors 👨‍🏫

With 16 years of experience teaching postgraduate (P.G.) classes and 18 years of undergraduate (U.G.) teaching, Prof. Neerati Prasad has been a pillar in the academic world. His dedication to nurturing young minds and guiding them toward excellence is evident in his long-standing role as a professor at Kakatiya University.Beyond teaching, Prof. Prasad’s research contributions have been extensive. He has spent 15 years in research, excluding the years dedicated to his M.Phil. and Ph.D. studies. His research interests are diverse and impactful, spanning Clinical Pharmacokinetics, Drug Transport, Pharmacokinetics and Drug Metabolism, Cancer Metastasis (with a focus on the role of phyto-polyphenols), Toxicological Studies, and the Pharmacological Screening of new chemical entities from natural sources 🌿. These fields of research hold immense significance for the development of novel therapeutic agents, making his work critical for both academia and the pharmaceutical industry.

Contributions and Research Focus 🔬

Prof. Neerati Prasad’s research has been groundbreaking in several key areas. During his M.Pharm., he conducted an insightful study on Bacteremia amongst Leprosy Patients, awarded in June 2002. However, his most notable work came during his Ph.D., where he explored the Isolation and Characterization of probable potential pharmacological agents from animals and their waste. This innovative research, completed in 2007, opened new avenues in pharmacological studies, contributing to the understanding of natural pharmacological agents.Prof. Prasad’s international experience includes his Post-Doctoral Fellowship (PDF) at SRI International in California, USA 🌍. There, he conducted advanced research in Tumor Glycomics, focusing on biomarker discovery, tumor targeting agents, and the regulation of metastasis by endogenous angioinhibitors. His work at the intersection of pharmacology and cancer research has contributed to a better understanding of metastasis and cancer treatment, positioning him as a key researcher in the field of oncology.

Accolades and Recognition 🏅

Prof. Prasad’s academic and research excellence has not gone unnoticed. He is a recipient of the prestigious C.V. Raman Fellowship, awarded by the University Grants Commission (UGC). This fellowship is given to distinguished scholars to encourage high-quality research. Additionally, during his Ph.D. journey, he was awarded a UGC Research Fellowship for his exceptional work. These accolades reflect not only his dedication to the field but also the high regard in which he is held by the academic community.

Impact and Influence 🌍

Prof. Neerati Prasad’s work has had a profound impact on the fields of pharmacology, oncology, and pharmaceutical sciences. His research on Cancer Metastasis and the role of natural compounds in regulating metastasis has been instrumental in developing new approaches to cancer treatment. Moreover, his contributions to Clinical Pharmacokinetics and Drug Metabolism have helped shape the development of safer and more effective drugs.His teaching has influenced countless students who have gone on to pursue successful careers in pharmacy and related fields. Through his mentorship, he has cultivated a generation of researchers and professionals who continue to contribute to the pharmaceutical sciences. His dedication to both teaching and research makes him a well-rounded academic whose influence is felt both inside and outside the classroom. 🎓

Legacy and Future Contributions 🌟

As a seasoned academic and researcher, Prof. Neerati Prasad’s legacy in the field of pharmaceutical sciences is already well-established. However, his journey is far from over. With a continued focus on cutting-edge research in Tumor Glycomics, Drug Transport, and Cancer Metastasis, his work holds the promise of further breakthroughs in these critical areas of healthcare. His research on the Pharmacological Screening of New Chemical Entities from Natural Sources is likely to lead to the discovery of novel therapeutic agents, offering new hope for the treatment of various diseases.In the years to come, Prof. Prasad’s influence will continue to grow as he inspires future generations of pharmacists and researchers. His commitment to advancing pharmaceutical sciences, both in India and internationally, ensures that his contributions will leave a lasting legacy. 🌍

Citations

A total of 667 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         667
  • h-index           41
  • i10-index        16

Notable Publications 

  • Title: A New Epoxy Steroid Isolated and Characterized from Bufo melanostictus Venom with Potential IL-6 along with TNF-α Inhibition and Spectroscopic Study for Structure and Vibrational Properties Using DFT
    Authors: Bonagani, N., Neerati, P., Prashanth, J., Byru, V.R.
    Journal: Journal of Molecular Structure
    Year: 2024.
  • Title: Hypoxia and Extracellular Matrix – Major Drivers of Tumor Metastasis
    Authors: Neerati, P., Polati, D.
    Journal: Hypoxia in Cancer: Significance and Impact on Cancer Therapy (Book Chapter)
    Year: 2023.
  • Title: Novel Indole Derivative as the First P-glycoprotein Inhibitor from the Skin of Indian Toad (Bufo melanostictus)
    Authors: Neerati, P., Munigadapa, S.
    Journal: Turkish Journal of Pharmaceutical Sciences
    Year: 2022.
  • Title: A New Steroidal Derivative from the Skin of Indian Toad (Bufo melanostictus) as a Hypolipidemic and CYP 3A Inhibitor
    Authors: Munigadapa, S.K., Neerati, P.
    Journal: Tropical Journal of Pharmaceutical Research
    Year: 2022.
  • Title: Gallic Acid Improved Amytryptiline Effect in Neuropathic Pain Induced by Partial Sciatic Nerve Ligation (Psnl) in Rats
    Authors: Neerati, P., Enumula, V.
    Journal: Natural Products Journal
    Year: 2021.

Ravindra Kumar | Medicinal Chemistry | Best Researcher Award

Published-on by Indian Scientist

Dr. Ravindra Kumar | Medicinal Chemistry | Best Researcher Award

CSIR-Central Drug Research Institute-India

Author Profile

Early Academic Pursuits 📚🎓

Dr. Ravindra Kumar’s journey into the world of scientific research began with a Master’s degree from the prestigious Delhi University. Eager to delve deeper into the realm of organic chemistry, he then joined the Council of Scientific and Industrial Research-National Chemical Laboratory (CSIR-NCL) in Pune as a Junior Research Fellow (JRF). Under the supervision of Dr. Ganesh Pandey, Dr. Kumar focused his Ph.D. research on the total synthesis of amaryllidaceae alkaloids, a class of naturally occurring compounds with potential medicinal properties. This work laid a solid foundation for his future in synthetic organic chemistry and sparked a lifelong dedication to drug discovery and innovation.

Professional Endeavors 🚀🏛️

After completing his Ph.D., Dr. Kumar expanded his research horizons by moving to Japan, a globally recognized hub for cutting-edge chemical research. His postdoctoral experience commenced at the Kyoto Institute of Technology (KIT) in 2011, followed by a stint at Osaka University, where he was appointed as a specially appointed assistant professor. These years honed his expertise in asymmetric catalysis and broadened his skills in multidisciplinary research. With more than six years of post-Ph.D. experience, Dr. Kumar had the opportunity to contribute to several breakthroughs in synthetic organic chemistry.In 2018, Dr. Kumar returned to India and joined the CSIR-Central Drug Research Institute (CDRI), Lucknow, in the Department of Medicinal and Process Chemistry. His focus on medicinal chemistry and process development significantly contributed to the institute’s ongoing mission of drug discovery and development. Since 2022, he has served as a Principal Scientist at CSIR-CDRI, leading a team of researchers focused on developing innovative therapeutic strategies.

Contributions and Research Focus 🧪🔍

Dr. Ravindra Kumar’s research focus spans the design and synthesis of novel boron-based drug candidates to combat drug-resistant microbial infections, commonly known as Antimicrobial Resistance (AMR). His team has made significant progress in this area by identifying boron-containing compounds with potential applications in treating AMR-related infections. For example, the compound S-022-044 has shown selective activity against Staphylococcus aureus, a notorious pathogen in AMR research.In addition to AMR, Dr. Kumar’s group focuses on CNS-related therapeutics. His research has identified novel hits for selective GPCR agonists like TGR5 and dopamine-D1/D5, which have demonstrated promising potential for treating post-stroke recovery and Parkinson’s disease. Compounds like S-022-252 (TGR5 agonist) and S-020-504 (dopamine-D1/D5 agonist) are in the translation phase for further study.Beyond medicinal chemistry, Dr. Kumar’s contributions to synthetic organic chemistry include groundbreaking work in stereo- and enantioselective synthesis of sp3-rich molecules. His research explores the desymmetrization of prochiral cyclohexadienones to create complex polycyclic compounds and heterocycles, which are crucial in drug development. His innovative approaches to p-quinol reactivity have also opened new pathways for site-selective multifunctional arenes, pushing the boundaries of chemical reactivity.

Accolades and Recognition 🏅🌍

Dr. Kumar’s research excellence is reflected in his impressive citation index of 600 and his 30 high-impact publications in prestigious journals, boasting a total impact factor of ~200 with an average impact factor of 7.5. His book, published by Wiley, has further solidified his reputation as an expert in medicinal chemistry and synthetic organic chemistry. Dr. Kumar’s work has also been recognized by national and international funding agencies, with grants from DST and SERB-CRG. His involvement in CSIR mission projects, such as the PAN-Cancer and antiviral programs, exemplifies his commitment to translating research into tangible healthcare solutions.Moreover, Dr. Kumar’s collaborative spirit is evident in his international and domestic partnerships. He has worked closely with Prof. Mary Grellier in France and biologists such as Dr. Sidharth Chopta (AMR), Dr. P.N. Yadav (CNS), and Dr. Rahul Sukla (Dengue) at CDRI, showcasing his interdisciplinary approach to solving complex biomedical problems. His professional membership in the Indian Society of Chemists and Biologists (ISCBC) as a lifetime member highlights his active engagement with the scientific community.

Impact and Influence 🌟🧠

Dr. Kumar’s research has a far-reaching impact, not only in terms of scientific innovation but also in terms of mentorship and student development. His students have excelled under his guidance, winning best paper awards for three consecutive years (2019-2021), a testament to his dedication to nurturing the next generation of scientists. By fostering a culture of excellence and curiosity in his laboratory, Dr. Kumar is ensuring that his contributions to chemistry will resonate long into the future.His work on non-infringing routes for high-value products in CSIR’s API mission projects demonstrates his ability to balance fundamental research with industrial applications, contributing to both academia and industry. This dual impact makes Dr. Kumar an invaluable asset to the scientific community.

Legacy and Future Contributions 🔮🏆

Dr. Ravindra Kumar’s legacy as a synthetic organic chemist and medicinal chemist is already well-established. His cutting-edge research in drug discovery, particularly in AMR and CNS therapeutics, has the potential to revolutionize treatment options for some of the most challenging diseases of our time. As he continues to lead his research team at CSIR-CDRI, his future contributions are likely to drive innovations in stereoselective synthesis, chemical reactivity, and medicinal chemistry.With his eyes set on further expanding the frontiers of organic chemistry and drug development, Dr. Kumar’s ongoing research and collaborations promise to bring novel therapeutic candidates to clinical use. His work in boron-based therapeutics and enantioselective synthesis will undoubtedly leave an indelible mark on the field, ensuring that his contributions continue to shape the future of medicinal chemistry and drug discovery.

Citations

A total of 562 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        562
  • h-index          32
  • i10-index       13

Notable Publications 

  • Discovery and Structure−Activity Relationships of 2,4,5-Trimethoxyphenyl Pyrimidine Derivatives as Selective D5 Receptor Partial Agonists
    • Authors: Kumar, S., Rastogi, S.K., Roy, S., Kumar, R., Yadav, P.N.
    • Journal: Bioorganic Chemistry
    • Year: 2024.
  • Anion-Relay Double Aza-Michael-Michael Cascades to Enone-Tethered Cyclohexadienones: Access to an Intricate Bridged Ring System
    • Authors: Chauhan, A., Patel, R.K., Yadav, A., Kant, R., Kumar, R.
    • Journal: Organic Letters
    • Year: 2024.
  • Polycyclic Pyrazoles from Alkynyl Cyclohexadienones and Nonstabilized Diazoalkanes via [3 + 2]-Cycloaddition/[1,5]-Sigmatropic Rearrangement/Aza-Michael Reaction Cascade
    • Authors: Patel, R.K., Jha, P., Chauhan, A., Kant, R., Kumar, R.
    • Journal: Organic Letters
    • Year: 2024.
  • Design, Synthesis, and Biological Evaluation of Novel Pyrimidine Derivatives as Bone Anabolic Agents Promoting Osteogenesis via the BMP2/SMAD1 Signaling Pathway
    • Authors: Rastogi, S.K., Khanka, S., Kumar, S., Singh, D., Sinha, A.K.
    • Journal: RSC Medicinal Chemistry
    • Year: 2024.
  • Arylsulfonic Anhydride as Thiol Surrogate for Sulfenylation of sp2 C−H Bond Through De-Oxygenative Reduction with Neutral Ionic Liquid: Scope and Mechanistic Studies
    • Authors: Rastogi, S.K., Equbal, D., Kumar, S., Kumar, R., Sinha, A.K.
    • Journal: Advanced Synthesis and Catalysis
    • Year: 2023.

Mohhammad Ramzan | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Dr. Mohhammad Ramzan | Pharmacology | Best Researcher Award

School of Pharmaceutical Sciences-India

Author Profile

Early Academic Pursuits

Dr. Mohhammad Ramzan began his academic journey in the field of pharmaceutical sciences with a commitment to excellence and innovation. He obtained his Bachelor of Pharmacy from Punjabi University, Patiala, in 2007, laying a strong foundation in pharmaceutical principles. His thirst for knowledge propelled him to pursue a Master of Pharmacy in Pharmaceutics from the same university, graduating in 2009. Dr. Ramzan’s academic journey culminated with a Ph.D. from Panjab University, Chandigarh, in 2023, where he focused on critical aspects of drug formulation and development. His dedication to understanding the intricacies of pharmaceuticals has been evident throughout his studies, marking him as a promising figure in the field. 📚

Professional Endeavors

With over 12 years of teaching and research experience, Dr. Ramzan has made significant contributions to pharmaceutical education and industry. Since August 2021, he has served as a Senior Research Associate Professor at the School of Pharmaceutical Sciences (SPS) at Lovely Professional University in Punjab, India. Prior to this, he was a Senior Research Fellow at the University Institute of Pharmaceutical Sciences (UIPS), Panjab University, where he contributed to various research projects from September 2015 to August 2021.His earlier roles included positions as an Assistant Professor at PCTE Institute of Pharmacy and as a Lecturer at Adesh Institute of Pharmacy and Biomedical Sciences. Dr. Ramzan’s diverse experiences in academia have allowed him to mentor numerous students, fostering a new generation of pharmaceutical scientists. 🎓

Contributions and Research Focus

Dr. Ramzan’s research interests are deeply rooted in Pharmaceutics, with a specialization in formulation development and optimization. His work includes the screening and optimization of formulation excipients using Design of Experiments (DoE) and Quality by Design (QbD) software. He has conducted extensive solubility analysis of active pharmaceutical ingredients (APIs) in various solvents using GastroPlus software, which is crucial for developing effective drug formulations.Additionally, Dr. Ramzan has made significant advancements in nanoparticulate technology, aiming to improve the biopharmaceutical performance of topical and parenteral antifungal agents. His research also encompasses toxicity testing in accordance with OECD guidelines, ensuring that pharmaceutical products are safe for consumer use.Dr. Ramzan has collaborated on industrial projects, notably developing lipidic nanocarriers for treating topical fungal infections in partnership with Hitech Formulation and the Biotechnology Industry Research Assistance Council (BIRAC). His research outcomes include six postgraduate theses, 27 publications, one international book chapter, and numerous conference presentations, showcasing his prolific contributions to the field. 💡

Accolades and Recognition

Dr. Ramzan’s work has garnered significant recognition in the academic community. He was awarded the UGC-BSR Fellowship in Sciences from 2015 to 2020 at Panjab University, acknowledging his research potential and contributions. His professional affiliations include being a life member of the Association of Pharmaceutical Teachers of India, reflecting his commitment to the advancement of pharmaceutical education.His extensive publication record, which includes 27 research papers and participation in various national and international conferences, demonstrates his influence and reputation in the field. These accolades not only validate his expertise but also inspire his colleagues and students alike. 🌟

Impact and Influence

Dr. Ramzan’s impact extends beyond his research and publications. By mentoring students and junior researchers, he plays a crucial role in shaping the future of pharmaceutical sciences. His focus on innovative drug delivery systems and formulation technologies directly addresses critical healthcare needs, particularly in treating resistant infections.Moreover, Dr. Ramzan actively engages with the pharmaceutical industry, bridging the gap between academia and practical applications. His collaborative projects aim to translate research findings into real-world solutions, significantly influencing the pharmaceutical landscape in India. 🌍

Legacy and Future Contributions

Looking ahead, Dr. Ramzan envisions expanding his research in pharmaceutics and drug formulation. He aims to explore new avenues in nanotechnology and sustainable pharmaceutical practices, focusing on developing safer and more effective medications. His commitment to fostering collaboration between academic institutions and the pharmaceutical industry is expected to lead to innovative solutions that enhance patient care.As he continues to inspire and educate future pharmacists, Dr. Mohhammad Ramzan’s legacy in the field of pharmaceutical sciences will undoubtedly be marked by his dedication to research, teaching, and the pursuit of excellence. Dr. Ramzan’s contributions are paving the way for advancements in pharmaceutical sciences, ensuring that his work will have a lasting impact on both the academic community and society at large.

Citations

A total of 214 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         214
  • h-index           30
  • i10-index        8

Notable Publications 

  • Ramzan, Mohhammad, Afzal Hussain, Tasneem Khan, Mohd Usman Mohd Siddique, Musarrat Husain Warsi.
    “Tolterodine tartrate loaded cationic elastic liposomes for transdermal delivery: in vitro, ex vivo, and in vivo evaluations.”
    Pharmaceutical Research, 2024.
  • Khan, Tasneem, Aziya Khan, Afzal Hussain, Ramzan, Mohhammad, Mudassar Shahid, Farhan Jalees Ahmad.
    “HSPiP and QbD oriented optimized green nanoemulsion to treat chloramphenicol contaminated water.”
    Journal of Molecular Liquids, 2024.
  • Jha, Ritwik Kumar and Ramzan, Mohhammad.
    “Biofabrication of nanoparticles: A Nature-inspired approach towards green synthesis.”
    European Journal of Cardiovascular Medicine, 2024.
  • Ramzan, Mohhammad, Mohammed Sabir, Sukhbir Singh, Abhijit Debnath.
    “Three-Dimensional Hydrogel Bioprinting Technology as a Scaffold of Novel Drug Delivery and Biomedical Devices: A Comprehensive Review.”
    BIO Web Conf., 2024.
  • Hussain, Afzal, Ramzan, Mohhammad*, Mohammad A. Altamimi, Tahir Khuroo, Mohd Usman Mohd Siddique, Osamah Abdulrahman Alnemer.
    “HSPiP, Computational Modeling, and QbD-Assisted Optimized Method Validation of 5‑Fluorouracil for Transdermal Products.”
    ACS Omega, 2024.

PRANJAL GUJARATHI | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Dr. PRANJAL GUJARATHI | Pharmacology | Best Researcher Award

Vidhyadeep Institute of Pharmacy, Vidhyadeep Univeirsty,Surat India

Author Profile

Early Academic Pursuits 🎓📚

Pranjal Gujarathi’s academic journey in pharmacology began with a deep-rooted interest in the sciences. He pursued a focused path in pharmacy and pharmacology, equipping himself with the knowledge necessary to excel in drug research, pharmacodynamics, and pharmacokinetics. His formal education laid the foundation for his future contributions in understanding drug mechanisms and their effects on biological systems. His commitment to academic excellence ensured that he built a strong grounding in pharmacological principles, which later translated into valuable insights in the field of drug discovery and therapeutic innovations.

Professional Endeavors 🧑‍🔬👨‍🏫

Pranjal Gujarathi has had an impactful professional career in pharmacology, spanning teaching and research roles. He began his professional journey as an Assistant Professor of pharmacology at Shree Dhanvantry Pharmacy College in Surat, Gujarat, from July 27, 2017, to May 15, 2021. During his tenure, Pranjal played a pivotal role in mentoring students, designing course curricula, and advancing the department’s research objectives. His teaching covered various aspects of pharmacology, from drug development to therapeutic applications, helping shape the next generation of pharmacists and pharmacologists.In February 2022, Pranjal transitioned into a Junior Research Fellow position at the same institution, a role that allowed him to dive deeper into pharmacological research. His current work focuses on exploring novel drug therapies, pharmacogenomics, and the development of more effective and safer medications. This shift from teaching to dedicated research underscores his versatility and his dedication to pushing the boundaries of pharmacological knowledge.

Contributions and Research Focus 🔬💉

Pranjal Gujarathi’s research has primarily revolved around drug discovery, preclinical studies, and pharmacodynamics, areas where he has made significant contributions. His work emphasizes the understanding of drug-receptor interactions, drug metabolism, and toxicology, all of which are crucial in the early stages of drug development. His role as a Junior Research Fellow allows him to collaborate with other scientists to test the efficacy and safety of new drug formulations before they enter clinical trials.His research is also centered on immunopharmacology and neuropharmacology, focusing on conditions like psoriasis and neurodegenerative diseases. These diseases represent significant challenges in pharmacotherapy, and Pranjal’s preclinical work has helped pave the way for potential breakthroughs in treatment. His expertise in pharmacokinetics, which studies how drugs move through the body, further enhances the precision of his research, allowing for more targeted and effective treatments.

Accolades and Recognition 🏆📜

Pranjal Gujarathi has been widely recognized for his contributions to pharmacology. His research has been published in esteemed journals such as International Immunopharmacology and Naunyn-Schmiedeberg’s Archives of Pharmacology. These publications highlight his growing influence in the scientific community, particularly in the areas of drug discovery in psoriasis and comprehensive studies on Hypericum perforatum in treating neurodegenerative diseases.His academic prowess and ability to translate complex pharmacological concepts into applied research have earned him accolades at conferences and symposia, where his papers have been well-received. These recognitions validate his dedication to advancing the field of pharmacology and underscore his commitment to improving public health through better pharmaceuticals.

Impact and Influence 🌍💊

Pranjal’s influence extends beyond the confines of academia and research. As an educator, he has inspired countless students to pursue careers in pharmacology, instilling in them a rigorous understanding of drug mechanisms and their therapeutic uses. His role in preclinical research has contributed to the development of safer, more effective drugs, influencing the way treatments for chronic diseases like psoriasis are approached.His research on the pharmacological properties of natural products like Hypericum perforatum has opened new avenues in understanding plant-based therapies, potentially offering more accessible and less invasive treatment options for complex conditions. This focus on both synthetic and natural compounds ensures that his work remains relevant across a broad spectrum of pharmacology.

Legacy and Future Contributions 🚀🔝

As Pranjal Gujarathi continues his journey in pharmacological research, his contributions are likely to have a lasting impact on the field. His focus on innovative drug therapies, coupled with his dedication to teaching, positions him as a significant figure in both the academic and scientific communities. His legacy will be defined not only by the drugs developed under his research but also by the knowledge and inspiration he imparts to his students and colleagues.Looking forward, Pranjal is set to make further strides in drug safety evaluations, exploring new territories in personalized medicine and pharmacovigilance. His work has the potential to revolutionize how we understand drug interactions and their effects on different populations, leading to more personalized and effective treatments for patients around the world.

Conclusion 🌟👨‍⚕️

Pranjal Gujarathi’s journey in pharmacology is a testament to his dedication, intellect, and passion for the field. From his early academic pursuits to his significant professional contributions, he continues to influence the development of new drugs and therapies, pushing the boundaries of what’s possible in pharmacological research. With a future that promises even more innovations, Pranjal’s work is sure to leave a lasting legacy in the realm of pharmaceutical sciences.

Notable Publications 

  • Title: Preclinical techniques for drug discovery in psoriasis
    Authors: Gujarathi, P.P., Korat, R.H., Gujarathi, P.S.
    Journal: International Immunopharmacology
    Year: 2024.
  • Title: Hypericum perforatum: A comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases
    Authors: Suryawanshi, M.V., Gujarathi, P.P., Mulla, T., Bagban, I.
    Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
    Year: 2024.
  • Title: Evaluation of acute intravenous toxicity of HEPES: Is Good’s buffer good and safe enough for clinical utilization in nuclear medicine?
    Authors: Guleria, M., Pallavi, K.J., Gujarathi, P.P., Das, T.
    Journal: Nuclear Medicine and Biology
    Year: 2024.

Manish Pal Singh | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Dr. Manish Pal Singh | Pharmacology | Best Researcher Award

Sharda School of Pharmacy, Sharda University, Agra-India

Author Profile

Early Academic Pursuits 🎓

Dr. Manish Pal Singh embarked on his academic journey with a passion for pharmacology. He earned his Bachelor of Pharmacy degree in June 2006 from Rajiv Academy for Pharmacy, Mathura, affiliated with Uttar Pradesh Technical University, Lucknow, where he achieved 64%. Building on his foundation, Dr. Singh pursued his Master of Pharmacy in Pharmacology from B.N. College of Pharmacy, Udaipur. His dedication to academic excellence was evident when he graduated in December 2008 with 73%. His thirst for knowledge didn’t stop there; he went on to achieve his Ph.D. in Pharmacology from the Faculty of Pharmaceutical Sciences, Bhupal Nobles University, Udaipur, completing his doctorate in March 2020.

Professional Endeavors 🧑‍🔬

Dr. Manish Pal Singh’s professional career is marked by his leadership and expertise in pharmacology. His role as a researcher and educator has been pivotal in shaping the future of aspiring pharmacists. His guidance and supervision of numerous Ph.D. and postgraduate projects reflect his commitment to nurturing young minds in the field. Notable among these are projects that explore topics like myocardial infarction, anticonvulsant activity, anti-inflammatory compounds, type 2 diabetes, and wound healing.With his in-depth knowledge of pharmacology, Dr. Singh has successfully supervised numerous Ph.D. scholars and postgraduate students, including Mr. Soumyadip Mukherjee, working on myocardial infarction, Ms. Varsha Snehi on anticonvulsant activities, and Mr. Hritik Verma on anti-inflammatory potential of heterocyclic compounds.

Contributions and Research Focus 🧑‍🏫

Dr. Singh’s research primarily focuses on the pharmacological evaluation of novel compounds, drug synthesis, and exploring the medicinal properties of natural substances. Some of his notable work includes evaluating Launea sarmentosa for Type 2 Diabetes Mellitus (T2DM) and studying the antioxidant and antibacterial properties of Shorea Robusta Resin.He has also supervised research on plants like Amaranthus polygamus for anti-diabetic properties and conducted significant work on stress models in rats using compounds like Vitis Vinifera and Withania Somnifera. His research extends to wound healing, diabetes management, and the exploration of pharmacological potential in various medicinal plants.

Accolades and Recognition 🏅

Dr. Singh’s contributions to the field of pharmacology have been recognized through various grants and awards. He has been honored with two significant grants from the DST (SERB), New Delhi, for organizing conferences and seminars, receiving INR 100,000 in both 2019 and 2022. His academic excellence during his M.Pharm was acknowledged with appreciation certificates across multiple semesters, underlining his dedication and leadership in his field.Moreover, Dr. Singh has published extensively in both national and international journals. His impressive publication record includes 42 articles (21 research papers and 21 review articles) and 27 articles indexed in Scopus and SCI/ESCI. He has also contributed 7 book chapters and presented his research in 21 posters and 5 oral presentations at various conferences.

Impact and Influence 💡

Dr. Singh’s research has a significant impact, with his Google Scholar citations reaching 573 and an H-index of 14. His i10-index stands at 15, indicating the high quality and influence of his research work in the academic community. Additionally, his Scopus H-index is 5, further demonstrating his contributions to the global scientific discourse.His work on pharmacological instruments and animal modeling has equipped him with the practical skills necessary for cutting-edge research. Dr. Singh is also well-versed in documentation processes for NAAC, PCI, and BOS, which has proven beneficial in managing academic and research programs.

Legacy and Future Contributions 🌟

Dr. Manish Pal Singh is not only shaping the present but also influencing the future of pharmacology. His leadership in project coordination and his positive approach to decision-making make him a valuable mentor to his students and colleagues. As he continues to guide doctoral and postgraduate research, Dr. Singh’s contributions will have a lasting impact on pharmacological research, both in India and internationally.Through his work on biological screening of drugs, virtual experimental pharmacological screening, and his hands-on experience with sophisticated pharmacological instruments, Dr. Singh ensures that his students are well-prepared for the future of research and innovation.

Citations

A total of 110 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        110
  • h-index           22
  • i10-index        5

Notable Publications 

  • Pharmacological update on Benincasa Hispida (Thunb.): A review
    • Authors: Singh, S., Gohil, K.J., Singh, M.P.
    • Journal: Pharmacological Research – Modern Chinese Medicine
    • Year: 2024.
  • Phytochemical and pharmacological aspects of genus Amaranthus
    • Authors: Singh, M.P., Goel, B., Kumar, R., Rathor, S.
    • Journal: Fitoterapia
    • Year: 2024.
  • Review on pharmacological activities of Justicia Gendarussa Burm F.
    • Authors: Jain, T., Singh, M.P., Bhardwaj, H., Gohil, K.J.
    • Journal: Pharmacological Research – Modern Chinese Medicine
    • Year: 2024.
  • Therapeutic Role of Desmodium Species on its Isolated Flavonoids
    • Authors: Singh, V., Singh, R., Singh, M.P., Katrolia, A.
    • Journal: Current Molecular Medicine
    • Year: 2024.
  • Autoimmunity and inflammation
    • Authors: Kumar, A., Chawla, V., Chawla, P.A., Singh, M.P., Singh, G.
    • Journal: Recent Developments in Anti-Inflammatory Therapy
    • Year: 2023.

RAGHU K G | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Dr. RAGHU K G | Pharmacology | Best Researcher Award

JUBILEE MISSION MEDICAL COLLEGE AND RESEARCH INSTITUTE,THRISSUR-India

Author Profile

Early Academic Pursuits 📚

Dr. K.G. Raghu’s journey in scientific research began with a strong academic foundation in the life sciences. He completed his Bachelor’s degree in Zoology, Botany, and Chemistry from Calicut University in 1983, achieving first-class honors. His passion for understanding biological systems led him to pursue a Master’s degree in Zoology from the same university, graduating in 1985 with first-class distinction.Dr. Raghu’s pursuit of knowledge continued with a Ph.D. from Saurashtra University, where his research focused on the effects of organomercurials pollution on the biochemical changes in the central nervous system of rats. His dissertation, titled “Effect of Organomercurials Pollution in Animals: Evaluation of Biochemical Changes in the Central Nervous System of Rat with Methylmercury and Chelators,” was completed under the supervision of Prof. P. P. Sood. This early work laid a solid groundwork for his future research in neurotoxicology and pharmacology.Following his Ph.D., Dr. Raghu undertook post-doctoral research at the Department of Biotechnology, Cochin University of Science & Technology. His research, supervised by Dr. C.S. Paulose, focused on neurotransmitter-receptor functions in mercury poisoning and the effects of chitosan.

Professional Endeavors 🔬

Dr. Raghu’s professional career is marked by significant contributions to the field of pharmacology and drug development, particularly in cardiovascular disease (CVD) and metabolic syndrome. His career began at the CSIR Central Drug Research Institute, Lucknow, where he served in various capacities from Scientist B to Senior Scientist between 1995 and 2008. His work focused on drug development for cardiovascular diseases and safety pharmacology, which helped advance therapeutic approaches in this critical area.In 2008, Dr. Raghu joined the CSIR-National Institute for Interdisciplinary Science & Technology (NIIST), Trivandrum, where he made remarkable contributions as a Senior Scientist, Principal Scientist, and eventually Senior Principal Scientist. His research during this period centered on the basic biology of metabolic syndromes and bioactives. He led pioneering studies on the development of leads for metabolic syndrome and explored bioactive compounds with therapeutic potential.In 2021, Dr. Raghu retired as Chief Scientist from NIIST but continued his impactful work as an Honorary Scientist at the Jubilee Mission Medical College & Research Institute, Trichur, Kerala. His research continues to address the fundamental biology of metabolic syndromes, further demonstrating his dedication to advancing medical science.

Contributions and Research Focus 🧬

Dr. Raghu’s research has had a profound impact on the understanding and treatment of metabolic syndromes and cardiovascular diseases. His studies have explored the biochemical mechanisms underlying these conditions and developed potential therapeutic leads. Notable contributions include:

  • Drug Development for Cardiovascular Diseases: Dr. Raghu’s early work involved developing and testing new drugs for cardiovascular conditions, focusing on safety pharmacology.
  • Metabolic Syndrome Research: His later research at NIIST was groundbreaking in exploring the basic biology of metabolic syndromes and developing bioactive compounds to combat these disorders. His work on compounds from natural sources has been particularly influential in identifying potential new treatments.

Dr. Raghu has also been instrumental in supervising Ph.D. and post-doctoral research, guiding several students and researchers in their scientific careers. His mentorship has led to significant advancements in the understanding of oxidative stress, cardiac hypertrophy, and metabolic syndrome.

Accolades and Recognition 🏆

Dr. Raghu’s contributions have been widely recognized in the scientific community. His work has not only advanced the field of pharmacology but has also earned him a place among the leading researchers in metabolic syndrome and cardiovascular diseases. He is a Fellow of the Indian Academy of Biomedical Sciences and the Kerala Academy of Sciences, highlighting his prominence and influence in the field.

Impact and Influence 🌍

Dr. Raghu’s research has had a lasting impact on the scientific understanding of cardiovascular and metabolic diseases. His innovative approaches and discoveries have paved the way for new therapeutic strategies and drug developments. His role as a mentor and guide to numerous researchers has further amplified his influence, fostering a new generation of scientists dedicated to advancing medical research.

Legacy and Future Contributions 🔮

As Dr. Raghu continues his work as an Honorary Scientist at the Jubilee Mission Medical College & Research Institute, his legacy is characterized by a commitment to advancing scientific knowledge and improving human health. His ongoing research aims to unravel further complexities of metabolic syndromes and develop effective interventions.Dr. Raghu’s career serves as an inspiring example of how dedication to research and mentoring can lead to significant advancements in science and medicine. His work not only contributes to the current understanding of critical health issues but also sets the stage for future breakthroughs in the field.

Citations

A total of 2610 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         2610
  • h-index           102
  • i10-index        31

Notable Publications

  • Title: Joubert syndrome causing mutation in C2 domain of CC2D2A affects structural integrity of cilia and cellular signaling molecules
    Authors: Jayarajan, R.O., Chakraborty, S., Raghu, K.G., Purushothaman, J., Veleri, S.
    Journal: Experimental Brain Research
    Year: 2024.
  • Title: Corrosion and in vitro characteristics of cerium phosphate based chemical conversion coating on AZ31 magnesium alloy
    Authors: Jayaraj, J., Kumar, S.A., Srinivasan, A., Arunchandran, C., Rajinikanth, V.
    Journal: Applied Surface Science
    Year: 2024.
  • Title: A clinically feasible diagnostic spectro-histology built on SERS-nanotags for multiplex detection and grading of breast cancer biomarkers
    Authors: Murali, V.P., Karunakaran, V., Murali, M., Sujathan, K., Maiti, K.K.
    Journal: Biosensors and Bioelectronics
    Year: 2023.
  • Title: Vanillic acid mitigates hyperinsulinemia induced ER stress mediated altered calcium homeostasis, MAMs distortion and surplus lipogenesis in HepG2 cells
    Authors: Mohan, S., Nair, A., Poornima, M.S., Raghu, K.G.
    Journal: Chemico-Biological Interactions
    Year: 2023.
  • Title: In vitro and in vivo anti-inflammatory and anti-arthritic effect of Tinospora cordifolia via modulation of JAK/STAT pathway
    Authors: George, G., Shyni, G.L., Mohan, S., Rajankutty, K., Raghu, K.G.
    Journal: Inflammopharmacology
    Year: 2023.

Archana Kapoor | Pharmaceutical | Best Researcher Award

Published-on by Indian Scientist

Prof. Archana Kapoor | Pharmaceutical | Best Researcher Award

Guru Jambheshwar University of Science & Technology-India

Author Profile

Early Academic Pursuits 📚

Born on October 25, 1978, Archana Kapoor embarked on her academic journey with a passion for pharmaceutical sciences. She pursued her undergraduate and postgraduate studies in Pharmaceutical Chemistry at Punjab University, Chandigarh, one of India’s premier institutions. Earning her post-graduation in 2003, she honed her expertise in drug discovery, medicinal chemistry, and pharmacokinetics. Her strong foundation in chemistry and pharmaceutical sciences earned her a GATE scholarship, a prestigious recognition of her academic excellence. Archana further enhanced her academic credentials by completing her Doctorate in Pharmaceutical Sciences from Guru Jambheshwar University of Science & Technology in 2016, marking a significant milestone in her pursuit of scientific knowledge and innovation.

Professional Endeavors 👩‍🔬

With almost 18 years of experience, Archana Kapoor’s career reflects her dedication to bridging the gap between academic research and industrial application. She commenced her professional journey in 2006 by joining Dr. Reddy’s Laboratories, Hyderabad, as a Scientist in the Discovery Chemistry section. During her tenure at Dr. Reddy’s, she gained invaluable experience in drug metabolism, pharmacokinetics, and advanced bioanalytical techniques such as HPLC and LC-MS/MS. Her work in the AMPK kinase project focused on developing lead series for Type-II Diabetes, contributing to the global efforts in combating this widespread condition.In 2016, Archana transitioned into academia, where she now serves as a Professor in the Department of Pharmaceutical Sciences at Guru Jambheshwar University of Science & Technology. Here, she plays a pivotal role in teaching, mentoring students, and spearheading research initiatives. Her ability to integrate real-world experience with academic learning has made her a respected figure among her peers and students alike.

Contributions and Research Focus 🔬

Archana Kapoor’s research portfolio is a testament to her deep commitment to advancing pharmaceutical sciences. Her work spans drug discovery, molecular docking, and pharmacokinetic analysis. One of her most significant contributions is her research on “5-Nitro-N-phenyl-3-(phenylamino)-1H-indazole-1-carboxamide Derivatives as Potential Anticancer Agents.” This study integrates chemical synthesis, in silico docking, and molecular dynamics simulations to explore new anticancer agents. The innovation in this research lies in its multi-faceted approach, targeting not just the synthesis of compounds but also analyzing their molecular interactions to optimize their efficacy as anticancer drugs.Her contributions to the discovery and development of new therapeutic agents extend beyond cancer treatment. While working at Dr. Reddy’s, Archana played a crucial role in the R&D sector, contributing to key projects that focused on metabolic disorders like Type-II Diabetes. Her experience with leading pharmaceutical companies and her academic background allows her to bring a comprehensive perspective to the challenges in drug discovery.

Innovations in Pharmaceutical Sciences 💡

Archana has consistently leveraged cutting-edge technology in her research, particularly in the integration of computational methods with experimental data. Her use of in silico techniques for drug discovery, including molecular docking and simulations, has streamlined the identification of promising drug candidates, saving both time and resources. By combining computational approaches with traditional experimental methods, Archana’s research has opened new avenues for discovering efficient and targeted therapeutic solutions.Her innovative methodologies reflect her forward-thinking approach and her drive to push the boundaries of pharmaceutical research. This integration of technology into drug discovery processes ensures that her work not only meets current scientific standards but also sets the stage for future advancements in the field.

Accolades and Recognition 🏆

Throughout her career, Archana Kapoor has been recognized for her exceptional contributions to pharmaceutical sciences. She has been the recipient of several awards and honors, including a prestigious Award of Honour for her exemplary efforts in education and research. Her research publications in renowned scientific journals and her presentations at international conferences have further solidified her standing as a leader in her field.Her work has also earned her recognition within the scientific community for her research on novel anticancer agents. The synthesis and analysis of new chemical compounds that can potentially contribute to cancer treatment has positioned her as an influential voice in pharmaceutical research. Additionally, her GATE scholarship during her postgraduate studies underscores her academic brilliance and commitment to excellence.

Impact and Influence 🌍

Archana Kapoor’s impact extends beyond her own research; she has become a mentor and a guide for the next generation of pharmaceutical scientists. As a professor, she has not only imparted knowledge but has also encouraged her students to engage in innovative thinking and research. Her leadership in various academic and research initiatives at Guru Jambheshwar University has led to the establishment of strong research networks and collaborations, fostering a culture of inquiry and innovation.Her participation in seminars, workshops, and conferences has further contributed to knowledge dissemination and professional networking. She has been instrumental in organizing academic events that bring together experts from various fields to discuss advancements in pharmaceutical sciences. Through these efforts, Archana has become a key figure in the pharmaceutical academic community, influencing both her peers and her students.

Legacy and Future Contributions 🌱

Looking ahead, Archana Kapoor is committed to continuing her research in drug discovery, with a specific focus on developing new therapeutic agents for cancer and metabolic diseases. Her interdisciplinary approach, combining chemistry, pharmacology, and computational methods, promises to drive future innovations in pharmaceutical research.In addition to her research contributions, Archana aims to continue her mentorship role, guiding young scientists and researchers in their academic and professional journeys. Her legacy is not only defined by her own research achievements but also by the impact she has had on shaping the future of pharmaceutical sciences through her students.

Citations

A total of 208 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         208
  • h-index           8
  • i10-index        6

Notable Publications 

  • Exploration of N‐(6‐Indazolyl) Benzenesulfonamide Derivatives as Potential Antioxidants and Antimicrobial Agents: Integrating Synthesis, In Silico Docking, and Bioactivity
    Authors: M. Yadav, R. Rao, S. Kumar, A. Kapoor
    Journal: ChemistrySelect, Vol. 8 (45), 2023
  • Development of 2-Dimensional and 3-Dimensional QSAR Models of Indazole Derivatives as TTK Inhibitors Having Anticancer Potential
    Authors: A.K. Mithlesh Yadav, Balasubramanian Narasimhan
    Journal: Current Chemistry Letters, Vol. 13 (1), 2023
  • Hybrid Descriptors–Conjoint Indices: A Case Study on Imidazole-Thiourea Containing Glutaminyl Cyclase Inhibitors for Design of Novel Anti-Alzheimer’s Candidates
    Authors: K. Bagri, A. Kapoor, P. Kumar, A. Kumar
    Journal: SAR and QSAR in Environmental Research, Vol. 34 (5), 2023
  • Anti-Hyperglycemic Evaluation of 2,4-Thiazolidinedione and Rhodanine Derivatives
    Authors: A. Kapoor, N. Khare
    Journal: Der Pharma Chemica, Vol. 8 (12), 2016
  • A Review on the Drug Delivery Strategies for Parasitic Infections: Scope and Assertion
    Authors: M. Bhatia, S. Kumar, A. Kapoor, S. Lohan
    Journal: Drug Delivery Letters, Vol. 12 (2), 2022.

Bandana Behera | Pharmacology | Women Researcher Award

Published-on by Indian Scientist

Assist Prof Dr. Bandana Behera - Pharmacology - Women Researcher Award 🏆 

C.V Raman Global University - India

Professional Profiles

Early Academic Pursuits

Her academic journey began with a passion for pharmacology, culminating in her attainment of a Ph.D. in Pharmacy from Utkal University in 2022. Prior to this, she completed her post-graduation in Pharmacology with an outstanding score of 76.2% from Utkal University in 2016. Her academic excellence was evident even during her undergraduate studies, where she achieved an impressive CGPA of 8.76 in Bachelor of Pharmacy from BPUT in 2014.

Professional Endeavors

Her professional career has been marked by a blend of teaching, research, and academic contributions. With three years of experience in teaching and research at UDPS, Utkal University, serving as a Junior Research Fellow (JRF) and Senior Research Fellow (SRF), she has honed her skills in both theoretical and practical aspects of pharmacology. Additionally, she has two years of teaching and academic experience at prestigious institutions like BIT-Hyderabad and RCPHS-Brahmapur, Odisha.

Contributions and Research Focus in Pharmacology

Her research endeavors have focused on various aspects of pharmacology, with a particular emphasis on cancer research. Her expertise spans basic cell and molecular biology techniques, including cell cultures, Western blotting, cytometry, RT-qPCR, cloning, and immunofluorescence staining. She has also delved into in vivo experiments in mice, exploring animal models of traumatic brain injury (TBI) and middle cerebral artery occlusion (MCAO). Her research interests extend to immunopharmacology, nano-medicine, and molecular cloning/docking, demonstrating a diverse and multifaceted approach to pharmacological research.

Pharmacology is the branch of medicine and biology concerned with the study of drugs and their effects on living organisms. It encompasses various aspects of drug action, including pharmacokinetics (the absorption, distribution, metabolism, and excretion of drugs) and pharmacodynamics (the study of how drugs interact with their targets to produce therapeutic or toxic effects).

Accolades and Recognition

Her contributions to pharmacological research have been acknowledged through various accolades and recognition. Notably, she has been granted two patents and has applied for one patent, showcasing her innovative research contributions. Additionally, she has published 17 research papers, participated in multiple workshops, and presented her work at numerous conferences and poster presentations. Her book publications and participation in AICTE FDA programs further underscore her commitment to advancing pharmaceutical sciences.

Impact and Influence

Through her extensive research and academic endeavors, she has made a significant impact on the field of pharmacology. Her research outputs, including patents, publications, and presentations, have contributed to the body of knowledge in cancer research, immunopharmacology, and nano-medicine. Furthermore, her expertise in various laboratory techniques and methodologies has influenced the research practices of her peers and students, fostering a culture of excellence and innovation in pharmacological research.

Legacy and Future Contributions

Her legacy in pharmacology is characterized by her dedication to advancing knowledge and innovation in the field. Moving forward, she aims to continue her research pursuits, exploring new avenues in cancer research, immunopharmacology, and nano-medicine. Through her mentorship and leadership, she seeks to inspire the next generation of pharmacologists and contribute to the development of novel therapies and interventions for improving healthcare outcomes.

Citations

  • Citations               23
  • h-index                  3

Notable Publications